Arcutis Biotherapeutics Inc (ARQT)
8.78
+0.31
(+3.66%)
USD |
NASDAQ |
Apr 29, 16:00
8.78
0.00 (0.00%)
After-Hours: 20:00
Arcutis Biotherapeutics Shareholders Equity (Quarterly): 88.67M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 88.67M |
| September 30, 2023 | 46.72M |
| June 30, 2023 | 80.51M |
| March 31, 2023 | 139.73M |
| December 31, 2022 | 209.58M |
| September 30, 2022 | 270.77M |
| June 30, 2022 | 195.38M |
| March 31, 2022 | 253.77M |
| December 31, 2021 | 297.68M |
| September 30, 2021 | 363.00M |
| Date | Value |
|---|---|
| June 30, 2021 | 414.49M |
| March 31, 2021 | 450.99M |
| December 31, 2020 | 270.62M |
| September 30, 2020 | 173.07M |
| June 30, 2020 | 208.92M |
| March 31, 2020 | 241.88M |
| December 31, 2019 | -65.03M |
| September 30, 2019 | -52.95M |
| December 31, 2018 | -23.99M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-65.03M
Minimum
Dec 2019
450.99M
Maximum
Mar 2021
199.32M
Average
209.25M
Median
Shareholders Equity (Quarterly) Benchmarks
| AdaptHealth Corp | 1.458B |
| Puma Biotechnology Inc | 53.44M |
| Adverum Biotechnologies Inc | 83.47M |
| Apellis Pharmaceuticals Inc | 194.52M |
| Karuna Therapeutics Inc (DELISTED) | 1.254B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 341.36M |
| Total Liabilities (Quarterly) | 252.70M |
| Debt to Equity Ratio | 2.276 |
| Current Ratio | 7.080 |
| Net Debt Paydown Yield | -0.32% |